Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Hit record highs
Diagnosed with cancer
To speak at RNC convention
Targets Trump immunity
Pay package lawsuit
'Candid Camera' star dies
Lead investigator suspended
Shots fired by off-duty cop
'Put his power up for sale'
'General Hospital' actor dies
13 missing hikers found
No Parkinson's treatments
Violent holiday weekend
Ruling in 'Rust' hearing
RNC's new abortion stance
Military land deals review
‘Rotten egg’ atmosphere
Napoleon’s pistols sold
New bird flu study
TSA sets screening record
Columbia removes 3 deans
Bloomberg donates $1B
Tire flies off during takeoff
VP pick likely this week
Sentinel ICBM cost grows
Inspections over mask issue
Cape Town homes destroyed
$50M deal with UConn
Settles antisemitism suit
Beryl claims 8 lives
Fritz reaches quarterfinals
US troops leave Niger
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Mounjaro, weight loss and Ozempic
Weight-loss drugs link to lower risk of obesity-related cancers
Blockbuster weight-loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests.
What to know about new study showing weight loss drugs can lower cancer risk
GLP-1
medications
such as Ozempic
may
help lower the
risk
of certain cancers. GLP-1
medications
such as Ozempic and Wegovy have exploded in popularity for their
weight loss
benefits and now new research is showing the
medications
may
help with another ...
Ozempic and Related Drugs May Reduce Cancer Risks, Study Claims
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
Healthline
3d
GLP-1 Drugs Like Ozempic May Reduce Risk of These 10 Cancers
Share on Pinterest A study finds that people with type 2 diabetes who took semaglutide were less likely to develop certain ...
The American Journal of Managed Care
3d
GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Wegovy
Feedback